跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
Tamoxifen and colchicine-modulated vinblastine followed by 5-fluorouracil in advanced renal cell carcinoma: A phase II study
Jin Hwang Liu
*
,
Muh Hwa Yang
, Frank Sheng Fan
, Chueh Chuan Yen
,
Wei Shu Wang
, Yen Hwa Chang
, Kuang Kuo Chen
, Po Min Chen
*
此作品的通信作者
生物藥學研究所
臨床醫學研究所
醫學系內科學科
研究成果
:
Article
›
同行評審
16
引文 斯高帕斯(Scopus)
總覽
指紋
指紋
深入研究「Tamoxifen and colchicine-modulated vinblastine followed by 5-fluorouracil in advanced renal cell carcinoma: A phase II study」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Confidence Interval
100%
Renal Cell Carcinoma
100%
5-fluorouracil (5-FU)
100%
Colchicine
100%
Vinblastine
100%
Phase II Study
100%
Advanced Renal Cell Carcinoma
100%
Multidrug Resistance
75%
Partial Response
50%
Chemotherapy
50%
Response Rate
50%
Complete Response
50%
Overall Survival Time
25%
Overall Survival
25%
Leukopenia
25%
Combination Therapy
25%
Additive Effect
25%
Favorable Risk
25%
Continuous Infusion
25%
Chemotherapy Efficacy
25%
Chemotherapy Resistance
25%
Median Overall Survival
25%
Treatment Toxicity
25%
Treatment-related Mortality
25%
Immunochemotherapy
25%
Intermediate Risk
25%
Poor Risk
25%
Pharmacology, Toxicology and Pharmaceutical Science
Renal Cell Carcinoma
100%
Colchicine
100%
Vinblastine
100%
Fluorouracil
100%
Tamoxifen
100%
Chemotherapy
57%
Multidrug Resistance
42%
Overall Survival
28%
Survival Time
14%
Combination Therapy
14%
Leukopenia
14%